A study published in the Journal of Cannabis Research found that daily cannabis users develop tolerance, resulting in less cognitive and psychomotor impairment compared to occasional users. The research suggests that current impairment assessment methods are insufficient and highlight the need for new, objective cognitive and psychomotor tests to better assess impairment and enhance public safety.
In recent years, the topic of the impact of cannabis on cognitive and psychomotor functions has gained significance, particularly in the context of public safety.
The latest research published in the Journal of Cannabis Research provides innovative insights into how cannabis use affects various aspects of mental and motor functioning. Researchers focused on comparing effects of use between occasional and daily users, delivering insightful and intriguing findings.
The issue of cannabis-induced cognitive and psychomotor impairment is crucial for public health, especially regarding road and occupational safety. Cannabis is the second most commonly detected substance among drivers involved in fatal road accidents in the USA.
However, current impairment assessment methods, such as blood THC levels, do not always correlate with actual impairment. This poses a significant challenge for law enforcement and employers who need more reliable impairment assessment methods.
For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.
The study aimed to investigate how different patterns of cannabis use affect cognitive and psychomotor performance. The study involved 86 healthy adults aged 25-45, divided into three groups: daily users (using at least once a day), occasional users (using 1-2 days a week), and non-users (not using within a month before the study).
Participants self-supplied and used their cannabis products, which had a THC content of 15-30%. Assessments were conducted before and after cannabis use using tablet-based tests that measured reaction time, break acceptance, and working memory. This approach allowed the study to reflect real-world cannabis use patterns, enhancing its credibility.
The study results confirm the hypothesis of developed tolerance to certain effects of cannabis in daily users. This tolerance may result in less cognitive and psychomotor impairment after cannabis use, which is significant for road and workplace safety. The finding that daily users can maintain accuracy in tasks at the expense of speed has important implications for understanding how cannabis affects cognitive functions in real-world situations, such as driving.
One of the key conclusions of the study is the potential application of the results to improve road and occupational safety. Current impairment assessment methods, such as blood THC tests, are insufficient. Introducing objective cognitive and psychomotor tests could better assess impairment and ensure greater safety on roads and in workplaces.
The study suggests several directions for future research that could provide more detailed information about the effects. It is worth investigating how different THC doses affect impairment and how quickly users can develop and lose tolerance. Expanding research to various demographic groups, including older adults and individuals with different health conditions, could increase the overall reliability of the findings.
The impact of cannabis on cognitive and psychomotor performance is complex and dependent on usage patterns. Daily users may develop tolerance to certain effects of cannabis, resulting in less cognitive and psychomotor impairment after cannabis use. These findings have significant implications for public safety and suggest the need for new, objective impairment assessment methods.
The study was published in the Journal of Cannabis Research, and its authors include Ashley Brooks-Russell, Julia Wrobel, Tim Brown, L. Cinnamon Bidwell, George Sam Wang, Benjamin Steinhart, Gregory Dooley, and Michael J. Kosnett. Their work provides important and innovative information that can help better understand the effects of cannabis on cognitive and psychomotor functions and develop more effective impairment assessment methods.
If you are interested in more detailed information about this study, the full results can be found in the article published in the Journal of Cannabis Research.
—
(Featured image by Elsa Olofsson via Unsplash)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…